Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000297943

Medchemexpress LLC 9-oxo-9H-indeno [1,2-b]pyrazine-2,3-dicarbonitrile | 924296-17-3 | 99.0% | 287.28 g·mol⁻¹ | C16H9N5O | 10 MG
SDP

Catalog No. 5000297943
Encompass_Preferred

DUB-IN-3 is a small-molecule deubiquitinase inhibitor reported to selectively inhibit USP8 and used in biochemical and cell-based research. Supplied as a light yellow solid with reported purity ≥99% and molecular weight 287.28 g·mol⁻¹, it is intended for research use only.

  • Potent USP8 inhibitor with reported IC50 ≈ 0.56 μM.
  • High purity suitable for research applications.
  • Available as a 10 mg solid and in larger pack sizes or solution forms.
  • Light yellow to yellow solid with defined storage conditions for powder and solution.
  • Documented CAS number and molecular formula for unambiguous identification.

Catalog No. 50-002-97943 Supplier Medchemexpress LLC Supplier No. HY5073710MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DUB-IN-3 is a small-molecule deubiquitinase inhibitor reported to selectively inhibit USP8 and used in biochemical and cell-based research. Supplied as a light yellow solid with reported purity ≥99% and molecular weight 287.28 g·mol⁻¹, it is intended for research use only.

  • Potent USP8 inhibitor with reported IC50 ≈ 0.56 μM.
  • High purity suitable for research applications.
  • Available as a 10 mg solid and in larger pack sizes or solution forms.
  • Light yellow to yellow solid with defined storage conditions for powder and solution.
  • Documented CAS number and molecular formula for unambiguous identification.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.